Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Jun 8:10:102.
doi: 10.1186/1477-7819-10-102.

Apoptotic activity in Libyan breast cancer

Affiliations

Apoptotic activity in Libyan breast cancer

Jamela Boder et al. World J Surg Oncol. .

Abstract

Background: We evaluated the relationship of the apoptotic activity index (AI) and the standardized mitotic-apoptotic ratio (SMI/AI) with clinicopathological features and prognosis in Libyan female breast cancer (BC) patients. We then compared our results with corresponding results in Finnish and Nigerian female BC patients.

Methods: Histological samples of breast carcinoma from 130 patients were retrospectively studied: an estimation of the apoptotic activity per square millimeter (expressed as apoptotic activity index (AI)), and standardized mitotic-apoptotic ratio (SMI/AI) was made, and the results compared with the clinicopathological features and the patient's survival.

Results: There was a statistically significant correlation between the AI and most of the clinicopathological features; the strongest association was observed for clinical stage lymph node (LN) status (P = 0.005). There were also correlations between AI and histological grade (P = 0.035), large tumor size (P = 0.011) and the clinical stage (P = 0.009). There were, however, prominent AI differences between Libyan, Nigerian and Finnish populations. The mean values of AI and SMI/AI in Libyan BC patients were 12.8 apoptotic figures per square millimeter and 2.8, respectively. The Libyan AI is slightly higher than in Nigeria, but much higher than in Finland. The differences between countries are seen throughout the samples as well as being present in certain subgroups. The survival analysis indicated that short survival time was associated with high apoptotic indices values and so can identify aggressive tumors and provide significant prognostic support. The cutoff (4 and 18 apoptosis/mm2) of AI might be applied as a quantitative criterion for Libyan BC to separate the patients into good, moderate and bad prognosis groups.

Conclusions: The results indicated that the differences in AI among the three countries may be due to the known variation in the distribution of genetic markers in these populations. Improvement in health care and introduction of screening programs, however, could be very helpful in the Libyan population.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Distribution of SMI/AI values in 130 Libyan female BCs.
Figure 2
Figure 2
Distributions of AI in 130 cases of Libyan BC.
Figure 3
Figure 3
Correlation between SMI and AI in 130 Libyan female BCs. Clearly, there is a correlation (P <0.001), but the correlation coefficient is low (r = 0.193).
Figure 4
Figure 4
Disease-specific survival (DSS) for 130 Libyan patients with BC divided according to AI cut point of four. The difference between the curves is highly significant (logrank P = 0.013).
Figure 5
Figure 5
Disease-specific survival (DSS) for 130 Libyan patients with BC divided according to AI cut point of 18. The difference between the curves is highly significant (logrank P = 0.001).

References

    1. van Slooten HJ, van de Vijver MJ, van de Velde CJ, van Dierendonck JH. Loss of Bcl-2 in invasive breast cancer is associated with high rates of cell death, but also with increased proliferative activity. Br J Cancer. 1998;77:789–796. - PMC - PubMed
    1. Koskinen PJ, Alitalo K. Role of myc amplification and overexpression in cell growth, differentiation and death. Semin Cancer Biol. 1993;4:3–12. - PubMed
    1. Wyllie AH. Apoptosis (the 1992 Frank Rose Memorial Lecture) Br J Cancer. 1993;67:205–208. - PMC - PubMed
    1. Baak JP, Van Dop H, Kurver PH, Hermans J. The value of morphometry to classic prognosticators in breast cancer. Cancer. 1985;56:374–382. - PubMed
    1. Ikpatt F. Nigerian breast cancer: prognostic value of histomorphometry. Turku: Annales Universitatis Turkuensis; 2002. p. 128.

MeSH terms